LFM-A13

Term ID

CHEBI:183517

Synonyms

(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide
2Z-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide
DDE-28

Definition

An enamide obtained by formal condensation of the carboxy group of (2Z)-2-cyano-3-hydroxybut-2-enoic acid with the amino group of 2,5-dibromoaniline. It is a dual-function inhibitor of Bruton's tyrosine kinase (BTK) and Polo-like kinases (PLK) that exhibits anticancer properties.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: aromatic amide dibromobenzene enamide enol nitrile ... Show All 6 Terms

aromatic amide dibromobenzene enamide enol nitrile secondary carboxamide Show first 5 Terms
has_role: antineoplastic agent apoptosis inducer EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor EC 2.7.11.21 (polo kinase) inhibitor geroprotector ... Show All 6 Terms

antineoplastic agent apoptosis inducer EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor EC 2.7.11.21 (polo kinase) inhibitor geroprotector platelet aggregation inhibitor Show first 5 Terms

Phenotype

Phenotype resulting from LFM-A13

Phenotype where environments contain LFM-A13

Phenotype modified by environments containing LFM-A13

Human Disease Model